Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CSBR
DateTimeSourceHeadlineSymbolCompany
10/26/20098:52AMPR Newswire (US)Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)NASDAQ:CSBR
10/13/20098:52AMPR Newswire (US)U.S. Patent Issued for Champions Biotechnology's Lead Oncology DrugNASDAQ:CSBR
09/14/20098:44PMPR Newswire (US)Champions Biotechnology Reports Fiscal 2010 First Quarter Financial ResultsNASDAQ:CSBR
09/10/20098:23AMPR Newswire (US)Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration AgreementNASDAQ:CSBR
09/09/200910:11AMPR Newswire (US)Champions Biotechnology to Present at Rodman & Renshaw's Eleventh Annual Healthcare ConferenceNASDAQ:CSBR
09/01/20098:55AMPR Newswire (US)Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech LeaderNASDAQ:CSBR
08/27/20094:26PMPR Newswire (US)Champions Biotechnology Reports Fiscal 2009 Full-Year Financial ResultsNASDAQ:CSBR
07/16/20098:22AMPR Newswire (US)Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) TeNASDAQ:CSBR
06/01/20098:52AMPR Newswire (US)Champions Biotechnology, Inc. Launches PersonalizedCancerTreatment.comNASDAQ:CSBR
04/08/20098:22AMPR Newswire (US)Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology BusinessNASDAQ:CSBR
03/18/20098:22AMPR Newswire (US)Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial ResultsNASDAQ:CSBR
02/05/20098:22AMPR Newswire (US)Champions Biotechnology, Inc.'s Doug Burkett, PhD, to Present at BIO CEO & Investor ConferenceNASDAQ:CSBR
07/30/20088:30AMPR Newswire (US)Champions Biotechnology Reports Fiscal 2008 Full-Year Financial ResultsNASDAQ:CSBR
06/17/20088:00AMPR Newswire (US)Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug CandidateNASDAQ:CSBR
05/07/20088:30AMPR Newswire (US)Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology DrugsNASDAQ:CSBR
05/06/20088:30AMPR Newswire (US)Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology DrNASDAQ:CSBR
04/23/20089:30AMPR Newswire (US)Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per ShareNASDAQ:CSBR
04/01/20088:00AMPR Newswire (US)Champions Biotechnology, Inc. Appoints New Board Members and Forms Management TeamNASDAQ:CSBR
03/06/20087:30AMPR Newswire (US)Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008NASDAQ:CSBR
10/23/20079:03AMPR Newswire (US)Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.NASDAQ:CSBR
08/14/20078:03AMPR Newswire (US)Dr. David Sidransky Appointed Director of Champions Biotechnology, Inc.NASDAQ:CSBR
06/11/200710:40AMPR Newswire (US)Dr. Manuel Hidalgo Appointed Director and Scientific Advisor of Champions Biotechnology, Inc.NASDAQ:CSBR
05/21/200710:30AMPR Newswire (US)Champions Biotechnology, Inc. Acquires Biomerk, Inc.NASDAQ:CSBR
02/14/20073:17PMPR Newswire (US)Champions Biotechnology, Inc. Acquires Rights to Cancer Drug CandidatesNASDAQ:CSBR
01/22/200710:33AMPR Newswire (US)Champions Sports, Inc. Changes Name to Champions Biotechnology, Inc.NASDAQ:CSBR
 Showing the most relevant articles for your search:NASDAQ:CSBR